Phorm Corporation Limited Announces Board Changes

SINGAPORE--(Marketwired - Feb 25, 2015) - Phorm Corporation (LSE: PHRM)

LSE: PHRM

25 February 2015

Phorm Corporation Limited
("Phorm" or the "Company")

Board Changes

Phorm (LSE: PHRM), a leading internet personalisation technology company, announces that Mr Lex Fenwick is being appointed as a Non-Executive Director of the Company and that Lord Lamont has resigned.

Board Changes
Phorm is pleased to announce that Mr Lex Fenwick will be appointed as a Non-Executive Director of the Company on 1 March 2015. Mr Fenwick is former CEO of Dow Jones & Co. and former CEO of Bloomberg L.P. Mr Fenwick brings with him invaluable experience from international finance, data and media businesses. Phorm also announces that Lord Lamont has resigned from the Board with immediate effect.

Kent Ertugrul, Chairman and CEO of Phorm, commented:
"We are delighted to welcome Lex to the Phorm Board. As a world-class CEO his experience will be of huge value as the business moves into the next stage of its development, generating large scale commercial revenue in major markets. We would also like to take this opportunity to thank Lord Lamont for his advice and support over the last 6 years and wish him well for the future."

Lex Fenwick commented:
"I am extremely excited to be joining the board of Phorm at a pivotal stage in its development. I have been watching the business for a considerable period of time and I look forward to helping them scale and reach their commercial potential."

Additional information on Mr Lex Fenwick
The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:

Alexius ("Lex") John Benedict Fenwick (aged 55)

Current Directorships/Partnerships		Past Directorships/Partnerships (last 5 years)
Selector Consultancy LLC		Dow Jones & Co.
		Bloomberg L.P.
		Bloomberg Inc.
		Bloomberg Communications Inc.
		Bloomberg SP Inc.
		Bloomberg (GP) Finance LLC
		Skillman Business Park LLC
		Bloomberg T-Book Inc.
		731 Funding LLC
		Bloomberg Korea LLC
		Bloomberg Finance Germany LLC
		Bloomberg Ventures LLC
		BLP Consulting Services Ltd.
		Bloomberg New Zealand
		Bloomberg Korea Ltd.
		Bloomberg Data Services (India) Private Limited
		BFM Financial Research Ltd.
		Bloomberg Venezuela SRL
		Bloomberg Bermuda Limited
		Bloomberg Telecommunications Pte Ltd.
		Bloomberg U.K. Limited
		Bloomberg Value-Added Network Services South Africa (Proprietary) Limited
		Bloomberg Chile Limitada

There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies.

-Ends-

For further information please contact: Phorm Corporation Limited
Andy Croxson (analysts and investors)		+44 (0) 203 397 6001
UK Investors
Mirabaud Securities LLP (Broker)		+44 (0) 207 321 2508
Jason Woollard
Peter Krens
Strand Hanson Limited (Nominated Adviser)		+44 (0) 207 409 3494
James Harris
Matthew Chandler
James Dance
US Investors
Lippert/Heilshorn and Associates (Investor Relations)		+1 212 838 3777
John Heilshorn

About Phorm
Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange